Jaguar health family company napo therapeutics named “best pharmaceuticals innovator of the year - europe”

Established in milan, italy in 2021, napo therapeutics is focused on expanding access to crofelemer, jaguar's novel oral plant-based prescription drug, in europe for orphan and/or rare diseases san francisco, ca / accesswire / november 19, 2024 / jaguar health, inc. (nasdaq:jagx) (jaguar) today announced that jaguar family company napo therapeutics has been named "best pharmaceuticals innovator of the year - europe" by the european, a quarterly business publication published by cp media global ltd in london. "we are very honored to receive this award," said massimo radaelli, phd, chief executive officer of napo therapeutics and president of jaguar international, "as we continue to be laser-focused on our mission of expanding access to crofelemer in europe for orphan and rare diseases.
JAGX Ratings Summary
JAGX Quant Ranking